ActivX Biosciences, Inc.

ActivX Biosciences, Inc., based in La Jolla, CA, USA, is a pioneer in the field of activity-based proteomics, the identification and analysis of active proteins. By focusing on protein activity, ActivX is addressing the biochemical mechanisms of disease more directly than standard genomics and proteomics techniques.

ActivX's chemistry platform profiles the activity level of proteins. The technology can be applied to solving some of the most important problems in drug discovery and development, including identification of novel drug targets, determination of target selectivity for drug candidates and the assessment of efficacy and toxicity for candidate and established drugs.

In December 2004 ActivX was acquired by Kyorin Pharmaceutical Co., Ltd. Japan (TSE:4560).

Visit ActivX